Kim Gaspar, PhD
Director Quality Assurance
Kim is the Director of Quality Assurance at Helix BioPharma Corp. An experienced quality
assurance professional with expertise in Canadian, US, and EU regulations, she has been
involved in all aspects of Phase I/II biopharmaceutical product development over the years,
including regulatory submissions, QC laboratory compliance, tech transfer and third-party
oversight of CMC activities, clinical QA, and bioanalytical data analysis. Kim joined Helix in 2000, transitioning into QA in 2003. She holds a B.Sc in Biochemistry and a Ph.D in Veterinary Physiological Sciences, both from the University of Saskatchewan.